Karyopharm Therapeutics
KPTI
KPTI
115 hedge funds and large institutions have $482M invested in Karyopharm Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
49
Reduced
34
Closed
17
Calls
$553K
Puts
$894K
Net Calls
-$341K
Net Calls Change
+$2.08M
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.41M |
| 2 |
Millennium Management
New York
|
-$3.64M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.77M |
| 4 |
DAM
Doheny Asset Management
Los Angeles,
California
|
-$1.58M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.38M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AAP
126
Ardsley Advisory Partners
Stamford,
Connecticut
| – | -$179K | -700 | Closed |
|
|
AIM
127
Assured Investment Management
New York
| – | -$94K | -370 | Closed |
|
128
Pacer Advisors
Malvern,
Pennsylvania
| – | -$83K | -324 | Closed |
|
|
AAMU
129
Amundi Asset Management US
Boston,
Massachusetts
| – | -$78K | -307 | Closed |
|
|
QT
130
Quantbot Technologies
New York
| – | -$72K | -282 | Closed |
|
|
MSFP
131
Mark Sheptoff Financial Planning
Glastonbury,
Connecticut
| – | -$14K | -53 | Closed |
|
|
PHK
132
Point72 Hong Kong
Hong Kong
| – | -$1K | -5 | Closed |
|